We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Novacyt S.a. | LSE:NCYT | London | Ordinary Share | FR0010397232 | EUR1/15TH (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.40 | 5.00% | 71.40 | 71.00 | 71.80 | 72.00 | 68.60 | 68.60 | 137,010 | 16:35:10 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
In Vitro,in Vivo Diagnostics | 22.49M | -25.73M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
02/3/2021 15:29 | Another thing to stress is that the only way to distinguish whether your symptoms from your vaccination are just side effects of the vaccine(1 in 5 get side effects) or COVID itself is to have a test. | undervaluedassets | |
02/3/2021 15:27 | If we close above 742p, double bottom formed, then a surge higher. The rns regarding government contracts must be released soon, or it could be viewed that any delay could be to let friends in beforehand. dyor | srpactive | |
02/3/2021 15:21 | Variants are now the key in the UK, France and the US. I wonder how the other European countries will deal with the detection of mutations which will be the main future big challenge - - | fuji99 | |
02/3/2021 15:21 | Massive mark up before close. 63000 buy means news imminent. £450000 is one mighty confidence booster.🔵 | smraynot | |
02/3/2021 14:45 | Some nice buying taking place.. | bobdown2 | |
02/3/2021 14:34 | 63k shares just bought. Someone has trust in this company! | picardy | |
02/3/2021 14:25 | Welcome back bountyhunter, good to see some normal posters returning to the thread again! Nice rise today!, long may it continue! | uk2day | |
02/3/2021 14:04 | VARIANT CAUSES SURGE TESTING: - - - | fuji99 | |
02/3/2021 14:04 | Bigger volumes in France. More than double the number of shares traded than here. | undervaluedassets | |
02/3/2021 14:04 | No volume supporting the rise and the AT trader is a net seller today (at the moment) on low volumes. | hatfullofsky | |
02/3/2021 14:01 | Very low volume and up 5% shows the market makers don't know where to go for stock. Sellers dried up it seems. | montyhedge | |
02/3/2021 13:54 | the Zoe COVID app has cases rising sadly | undervaluedassets | |
02/3/2021 13:53 | Tipped MHC here when they were 2p. Now 5.5p. | spacedust | |
02/3/2021 13:52 | LooksLike the kingRampr backIn here after lastPump&Dump. RedFlags | andymunchkin | |
02/3/2021 13:48 | Global coronavirus numbers edging back up after weeks of decline, says WHO: "By Erin Cunningham and Derek Hawkins March 2, 2021 at 2:40 p.m. GMT+1 - Washington Post. Please Note The global number of new coronavirus cases rose for the first time in nearly two months, the World Health Organization said Monday, blaming the surge in infections on circulating variants and premature efforts to lift public health restrictions. Cases over the past week jumped in every region except for Africa and the Western Pacific, the U.N. agency said, after declining for six weeks straight. In the United States, a steady drop in new cases last month also appeared to be leveling off and there are fears it could reverse course amid yet another wave of infections. Here are some significant developments: President Biden is set to announce Tuesday that pharmaceutical giant Merck & Co. will help make Johnson & Johnson’s coronavirus vaccine in an an unusual pact between competitors that could boost the supply of the newly authorized vaccine. The administration brokered the arrangement. The government’s top infectious-disease expert, Anthony S. Fauci, on Monday reiterated that the United States will stick to a plan to inoculate tens of millions of Americans with two doses of Pfizer-BioNTech̵ After a study from England showing that the first dose of the Oxford-AstraZeneca vaccine sharply reduced the risk of serious illness and death among the elderly, France has reversed its position and authorized the vaccine for the aged. While much of the world is using restrictions and vaccines to try to tame the coronavirus, Brazil’s outbreak is worse than it has ever been. A new study reports there have been hundreds of covid-linked attacks against health-care workers globally over the past year. More than 513,000 people have died of the coronavirus in the United States with the rolling weekly average of new cases and deaths both rising by 4 percent. Sign up for our coronavirus newsletter | Mapping the spread of the coronavirus: Across the U.S. | Worldwide | Vaccine tracker | Has someone close to you died of covid-19? Share your story with The Washington Post. | fuji99 | |
02/3/2021 13:40 | Next rns will be the one that's lites the blue touch paper for take off to 1400p.https://mobile | montyhedge | |
02/3/2021 13:35 | You get vaccinated for COVID once only (or once a year). You might be tested for COVID dozens of times a year (vaccinated or not). | undervaluedassets | |
02/3/2021 13:34 | Back in here, it looks like the recent downtrend has been broken and this is probably the best Covid test company out there. Yet more tests will be needed globally for quite some time to come and the new developments re antibody and lamp tests are very interesting. They will no doubt be best in class as with the existing antigen testing. It's also interesting to note that GM is focused on building a sustainable diagnostics company for the long term and will be updating us on that before long. " 24 February 2021 - Novacyt ( EURONEXT GROWTH: ALNOV; AIM: NCYT ), an international specialist in clinical diagnostics, announces an update on the progress of its near-term research and development programmes , including the expansion of its product portfolio, clinical trial activity and the publication of independent validations of the Company's COVID-19 tests. In parallel with the current focus of continuing to maximize the opportunity for COVID-19 testing, the Company is also continuing to build on its strategy for delivering a sustainable, long-term diagnostics business. Novacyt intends to present these plans during Q2 2021. The expansion of the Company's COVID-19 portfolio continues to address the rapidly evolving diagnostics market..." | bountyhunter | |
02/3/2021 13:26 | yup they are up 6.5% we are up 4.5% catching up to do with French listing | undervaluedassets | |
02/3/2021 13:24 | Froggies have just jumped again. | freedosh | |
02/3/2021 13:22 | looking better this stock.. makes sense All I ever hear on the news is about testing. | undervaluedassets | |
02/3/2021 13:13 | andymunchkin - Get a Nova Covid 19 test for the sake of your health before it's too late. You may have a re-occurring repetitive long Covid syndrome. | fuji99 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions